Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicans

Abstract Candida albicans is the most common cause of life-threatening fungal infection in the developed world but remains a therapeutic challenge. Protein kinases have been rewarding drug targets across diverse indications but remain untapped for antifungal development. Previously, screening kinase...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily Puumala, Meganathan Nandakumar, Bonnie Yiu, Peter J. Stogios, Benjamin G. Strickland, Robert Zarnowski, Xiaoyu Wang, Noelle S. Williams, Alexei Savchenko, David R. Andes, Nicole Robbins, Luke Whitesell, Timothy M. Willson, Leah E. Cowen
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-57346-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849762424512577536
author Emily Puumala
Meganathan Nandakumar
Bonnie Yiu
Peter J. Stogios
Benjamin G. Strickland
Robert Zarnowski
Xiaoyu Wang
Noelle S. Williams
Alexei Savchenko
David R. Andes
Nicole Robbins
Luke Whitesell
Timothy M. Willson
Leah E. Cowen
author_facet Emily Puumala
Meganathan Nandakumar
Bonnie Yiu
Peter J. Stogios
Benjamin G. Strickland
Robert Zarnowski
Xiaoyu Wang
Noelle S. Williams
Alexei Savchenko
David R. Andes
Nicole Robbins
Luke Whitesell
Timothy M. Willson
Leah E. Cowen
author_sort Emily Puumala
collection DOAJ
description Abstract Candida albicans is the most common cause of life-threatening fungal infection in the developed world but remains a therapeutic challenge. Protein kinases have been rewarding drug targets across diverse indications but remain untapped for antifungal development. Previously, screening kinase inhibitors against C. albicans revealed a 2,3-aryl-pyrazolopyridine, GW461484A (GW), which targets casein kinase 1 (CK1) family member Yck2. Here, we report optimization of GW via two complementary approaches, synthesis of bioisosteres possessing an imidazo[1,2-a]pyridine core, and R-group substitution of GW’s pyrazolo[1,5-a]pyridine core. Characterization of compounds reveals two 6-cyano derivatives with improved pharmacological properties that retain whole-cell bioactivity and selectivity for fungal Yck2 compared to human CK1α. Efficacy studies in mice indicate both analogs possess single-agent activity against C. albicans resistant to first-line echinocandin antifungals and potentiate non-curative echinocandin treatment. Results validate Yck2 as an antifungal target and encourage further development of inhibitors acting by this previously unexploited mode of action.
format Article
id doaj-art-746af135086e4ba09862bfc8d373c3ab
institution DOAJ
issn 2041-1723
language English
publishDate 2025-03-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-746af135086e4ba09862bfc8d373c3ab2025-08-20T03:05:45ZengNature PortfolioNature Communications2041-17232025-03-0116111610.1038/s41467-025-57346-zStructure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicansEmily Puumala0Meganathan Nandakumar1Bonnie Yiu2Peter J. Stogios3Benjamin G. Strickland4Robert Zarnowski5Xiaoyu Wang6Noelle S. Williams7Alexei Savchenko8David R. Andes9Nicole Robbins10Luke Whitesell11Timothy M. Willson12Leah E. Cowen13Department of Molecular Genetics, University of TorontoStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel HillDepartment of Molecular Genetics, University of TorontoDepartment of Chemical Engineering and Applied Chemistry, University of TorontoStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel HillDepartment of Medicine, University of Wisconsin-MadisonDepartment of Biochemistry, University of Texas Southwestern Medical SchoolDepartment of Biochemistry, University of Texas Southwestern Medical SchoolDepartment of Chemical Engineering and Applied Chemistry, University of TorontoDepartment of Medicine, University of Wisconsin-MadisonDepartment of Molecular Genetics, University of TorontoDepartment of Molecular Genetics, University of TorontoStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel HillDepartment of Molecular Genetics, University of TorontoAbstract Candida albicans is the most common cause of life-threatening fungal infection in the developed world but remains a therapeutic challenge. Protein kinases have been rewarding drug targets across diverse indications but remain untapped for antifungal development. Previously, screening kinase inhibitors against C. albicans revealed a 2,3-aryl-pyrazolopyridine, GW461484A (GW), which targets casein kinase 1 (CK1) family member Yck2. Here, we report optimization of GW via two complementary approaches, synthesis of bioisosteres possessing an imidazo[1,2-a]pyridine core, and R-group substitution of GW’s pyrazolo[1,5-a]pyridine core. Characterization of compounds reveals two 6-cyano derivatives with improved pharmacological properties that retain whole-cell bioactivity and selectivity for fungal Yck2 compared to human CK1α. Efficacy studies in mice indicate both analogs possess single-agent activity against C. albicans resistant to first-line echinocandin antifungals and potentiate non-curative echinocandin treatment. Results validate Yck2 as an antifungal target and encourage further development of inhibitors acting by this previously unexploited mode of action.https://doi.org/10.1038/s41467-025-57346-z
spellingShingle Emily Puumala
Meganathan Nandakumar
Bonnie Yiu
Peter J. Stogios
Benjamin G. Strickland
Robert Zarnowski
Xiaoyu Wang
Noelle S. Williams
Alexei Savchenko
David R. Andes
Nicole Robbins
Luke Whitesell
Timothy M. Willson
Leah E. Cowen
Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicans
Nature Communications
title Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicans
title_full Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicans
title_fullStr Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicans
title_full_unstemmed Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicans
title_short Structure-guided optimization of small molecules targeting Yck2 as a strategy to combat Candida albicans
title_sort structure guided optimization of small molecules targeting yck2 as a strategy to combat candida albicans
url https://doi.org/10.1038/s41467-025-57346-z
work_keys_str_mv AT emilypuumala structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT meganathannandakumar structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT bonnieyiu structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT peterjstogios structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT benjamingstrickland structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT robertzarnowski structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT xiaoyuwang structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT noelleswilliams structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT alexeisavchenko structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT davidrandes structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT nicolerobbins structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT lukewhitesell structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT timothymwillson structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans
AT leahecowen structureguidedoptimizationofsmallmoleculestargetingyck2asastrategytocombatcandidaalbicans